跳至主要内容
临床试验/NL-OMON35618
NL-OMON35618招募中不适用

Detection and evaluation of antibody formation against biologics in psoriasis - evaluation of antibody formation against biologics in psoriasis

Academisch Medisch Centrum0 个研究点目标入组 240 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Written informed consent
  • - Patients diagnosed with chronic plaque type psoriasis
  • - Treatment with a biologic (etanercept, adalimumab, infliximab or efalizumab) for chronic moderate to severe plaque psoriasis started not longer than 52 weeks before.
  • - Consecutive patients starting treatment with a biologic (etanercept, adalimumab, infliximab or efalizumab) for chronic plaque psoriasis.

排除标准

  • - Previous treatment with the same biologic.
  • - Patients unable to comply with the requirements of the study

研究者

相似试验

Detection and evaluation of antibody formation... | 临床试验